A 7-year-old Georgia boy appears to have defeated a rare cancer after previously overcoming a different rare cancer, this time after receiving a bone marrow transplant from his own father. The boy faced two different rare cancers, and his recovery marks a hopeful outcome in a battle that stretched across repeat rounds of treatment.
The child's story was reported by FOX 5 Atlanta, which covered the boy's case and his father's role as his bone marrow donor. Parent-to-child transplants like this one are classified medically as haploidentical transplants, meaning the donor shares exactly half of the patient's HLA genetic markers rather than a full match, according to research published by the National Institutes of Health. That half-match approach allows more than 95% of patients without a fully matched donor to still find a viable family candidate, the same research notes.
That science matters because most families never find a perfect match close to home. Registry data compiled by the National Marrow Donor Program shows roughly 70% of patients who need a blood stem cell or bone marrow transplant do not have a fully matched donor within their immediate family, forcing many to search public registries instead. Those odds are especially steep for some patients: the same registry data shows the chance of finding a fully matched unrelated donor ranges from 79% for White patients down to just 29% for Black or African American patients, a gap tied to underrepresentation on donor registries.
Why Parents Can Step In When a Perfect Match Isn't There
Because a parent is always a guaranteed 50% genetic match to a biological child, haploidentical transplants have become a critical option for patients who would otherwise have nowhere else to turn. In this case, the boy's father was able to serve as the donor for his son, per the original report from FOX 5 Atlanta.
Metro Atlanta families facing pediatric blood cancers have access to one of the most active transplant programs in the country. Children's Healthcare of Atlanta's Aflac Cancer and Blood Disorders Center performed 81 transplants in 2025 alone and maintains 100-plus-day post-transplant survival rates that exceed national averages, according to Children's Healthcare of Atlanta.
A Familiar Fight for Georgia Families
This is not the only Georgia family to make headlines this year over a repeat pediatric blood cancer battle. Hoodline previously reported on a 6-year-old who shaved his head for cousin undergoing a second bone marrow transplant for relapsed Acute Myeloid Leukemia after that Loganville boy's 13-year-old cousin relapsed. The story also touched on pediatric cancer treatment.
Nationally, leukemias remain the largest single category of childhood cancer. The American Cancer Society projects roughly 9,680 children under age 15 will be diagnosed with cancer in the United States in 2026, with leukemias making up more than a quarter of those cases. The same organization reports that 5-year relative survival rates for pediatric cancer overall have climbed to nearly 85% in 2026, up from roughly 58% in the mid-1970s, a shift credited to advances in clinical trials and transplantation protocols.
The Toll Behind the Recovery
Beating a rare blood cancer twice, however, does not come without steep costs. Financial analysis from the Get REDD Foundation indicates a single bone marrow transplant procedure can exceed $1 million in direct medical costs, with additional non-medical burdens like extended hospital stays, travel, and parents' lost wages compounding the strain on families.
For this 7-year-old and his father, the outcome is personal: a fight against two different cancers that, according to the original FOX 5 Atlanta report, he appears to have won.
